Ohio’s blueprint for manufacturing innovation is one the whole country should model, with the talent, history and culture to lead the charge on the global stage. And now, we need the policies to match ...

But Amgen’s true success stems from putting people first. By creating an environment where innovation, inclusion and ...

A nine percent increase in 2024 helped propel Ohio State to ranking 12th in the nation in total research funding, and sixth for industrial research. Ohio State recorded nearly $1.6 billion in research ...

A variety of potentially life-saving medications are available online, including Insulin Lispro, Farxiga and Tikosyn. There ...

TrumpRx, a new government website through which Americans can purchase discounted drugs, has officially been launched. The website was first announced in the fall of 2025 and went live on Thursday, ...

The prices would reflect discounts the White House said it has negotiated with more than a dozen drug companies under the "most favored nation." ...

Congress has approved $9.5 million in federal funding to support a new advanced manufacturing hub at Columbus State Community ...

Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said Tuesday as it presented quarterly financial results. Amgen explained that ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Amgen Inc. (AMGN) on Tuesday reported fourth-quarter profit of $1.33 billion. On a per-share basis, the Thousand Oaks, California-based ...

Ohio State University ranks 12th for research expenditures at $1.58 billion, marking a significant climb nationally.

This is read by an automated voice. Please report any issues or inconsistencies here. Amgen, a Thousand Oaks-based biotechnology giant, has acquired Dark Blue Therapeutics Ltd., a privately held ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.